RAFFLES ASSOCIATES LP – Lineage Cell Therapeutics, Inc. Transaction History
RAFFLES ASSOCIATES LP portfolio value:
$2.35M
portfolio value
RAFFLES ASSOCIATES LP quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +7.77% | 150K shares | -699K | $1.13 | 2.08M |
| Q2 2022 | share | Increase | +47.81% | 624.44K shares | 1.03M | $1.58 | 1.93M |
| Q1 2022 | share | Increase | +140.27% | 762.50K shares | 679K | $1.54 | 1.30M |
| Q4 2021 | share | Increase | +480.82% | 450K shares | 1.09M | $2.5 | 543.59K |
| Q3 2021 | share | Increase | +114.71% | 50K shares | 112K | $2.52 | 93.59K |
| Q2 2021 | share | 0.00% | 0 shares | 22K | $2.85 | 43.59K | |
| Q1 2021 | share | Increase | 0.00% | 43.59K shares | 102K | $2.35 | 43.59K |